Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...
4 studies found for:    USL261
Show Display Options
Rank Status Study
1 Terminated A Long-term Safety and Tolerability Study of USL261 in Patients With Seizure Clusters
Condition: Epilepsy
Intervention: Drug: USL261
2 Recruiting Study to Evaluate the Long-term Safety and Tolerability of USL261 in Patients With Seizure Clusters
Condition: Epilepsy
Intervention: Drug: USL261
3 Completed Study to Evaluate the Safety and Efficacy of USL261 in Patients With Increased Bouts of Seizure Activity in the EMU
Condition: Epilepsy
Interventions: Drug: USL261;   Drug: Placebo
4 Recruiting Study to Evaluate the Safety and Efficacy of USL261 (Intranasal Midazolam) in Patients With Seizure Clusters
Condition: Epilepsy
Interventions: Drug: USL261;   Drug: Placebo

Study has passed its completion date and status has not been verified in more than two years.